Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Ghofrani, HA; Distler, O; Gerhardt, F; Gorenflo, M; Grunig, E; Haefell, WE; Held, M; Hoeper, MM; Kahler, CM; Kaemmerer, H; Klose, H; Kollner, V; Kopp, B; Mebus, S; Meyer, A; Miera, O; Pittrow, D; Riemekasten, G; Rosenkranz, S; Schranz, D; Voswinckel, R; Olschewski, H.
Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010.
DEUT MED WOCHENSCHR. 2010; 135 Suppl 3(4): S87-101.
Doi: 10.1055/s-0030-1263316
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension have been adopted for Germany. The guidelines contain detailed recommendations for the treatment of pulmonary arterial hypertension (PAH). However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to the treatment of PAH. This commentary summarizes the results and recommendations of the working group on treatment of PAH.
- Find related publications in this database (using NLM MeSH Indexing)
- Algorithms -
- Anti-Arrhythmia Agents - therapeutic use
- Anticoagulants - therapeutic use
- Calcium Channel Blockers - therapeutic use
- Combined Modality Therapy -
- Cooperative Behavior -
- Cyclic Nucleotide Phosphodiesterases, Type 5 - antagonists and inhibitors
- Digoxin - therapeutic use
- Drug Therapy, Combination -
- Evidence-Based Medicine -
- Exercise Therapy -
- Female -
- Germany -
- Humans -
- Hypertension, Pulmonary - genetics Hypertension, Pulmonary - psychology Hypertension, Pulmonary - rehabilitation
- Interdisciplinary Communication -
- Oxygen Inhalation Therapy -
- Patient Care Team -
- Phosphodiesterase Inhibitors - therapeutic use
- Pregnancy -
- Prostaglandins - therapeutic use
- Receptors, Endothelin - antagonists and inhibitors
- Vasodilator Agents - therapeutic use
- Find related publications in this database (Keywords)
- pulmonary arterial hypertension (PAH)
- treatment
- prostanoids
- endothelin receptor antagonists
- phosphodiesterase type 5 inhibitors